Stock Analysis

Balaji Amines Third Quarter 2025 Earnings: EPS: ₹10.24 (vs ₹15.24 in 3Q 2024)

NSEI:BALAMINES
Source: Shutterstock

Balaji Amines (NSE:BALAMINES) Third Quarter 2025 Results

Key Financial Results

  • Revenue: ₹3.21b (down 16% from 3Q 2024).
  • Net income: ₹331.9m (down 33% from 3Q 2024).
  • Profit margin: 10% (down from 13% in 3Q 2024). The decrease in margin was driven by lower revenue.
  • EPS: ₹10.24 (down from ₹15.24 in 3Q 2024).
earnings-and-revenue-growth
NSEI:BALAMINES Earnings and Revenue Growth February 14th 2025

All figures shown in the chart above are for the trailing 12 month (TTM) period

Balaji Amines Earnings Insights

Looking ahead, revenue is forecast to grow 21% p.a. on average during the next 3 years, compared to a 13% growth forecast for the Chemicals industry in India.

Performance of the Indian Chemicals industry.

The company's shares are down 14% from a week ago.

Balance Sheet Analysis

Just as investors must consider earnings, it is also important to take into account the strength of a company's balance sheet. We've done some analysis and you can see our take on Balaji Amines' balance sheet.

Valuation is complex, but we're here to simplify it.

Discover if Balaji Amines might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

About NSEI:BALAMINES

Balaji Amines

Engages in the manufacture and sale of methylamines, ethylamines, and derivatives of specialty chemicals and pharma excipients in India.

Flawless balance sheet established dividend payer.